The first is in its incorporation into current screening protocols, for example, where Protein Z levels could be measured at the same time as CA‐125 levels and both could be assessed through the ovarian cancer risk estimation algorithm ROCA. Here, TMBIM4 is linked to ovarian carcinoma.